HomeONCO • STO
add
Oncopeptides AB
Previous close
kr 1.95
Day range
kr 1.94 - kr 2.03
Year range
kr 1.10 - kr 3.73
Market cap
181.36M SEK
Avg Volume
898.80K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
In the news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 13.27M | 161.57% |
Operating expense | 73.19M | 3.89% |
Net income | -60.67M | 10.39% |
Net profit margin | -457.29 | 65.74% |
Earnings per share | — | — |
EBITDA | -59.22M | 8.97% |
Effective tax rate | -0.08% | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 107.22M | 2.29% |
Total assets | 173.41M | -13.16% |
Total liabilities | 179.25M | -13.87% |
Total equity | -5.84M | — |
Shares outstanding | 209.20M | — |
Price to book | -65.00 | — |
Return on assets | -71.64% | — |
Return on capital | -96.96% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -60.67M | 10.39% |
Cash from operations | -68.32M | -1.42% |
Cash from investing | — | — |
Cash from financing | -2.04M | -1.59% |
Net change in cash | -71.31M | -3.98% |
Free cash flow | -38.60M | 12.43% |
About
CEO
Founded
2000
Website
Employees
75
